Pricing Log in Create free account

Celldex Therapeutics, Inc. (CLDX) vs Pharvaris N.V. (PHVS)

Celldex Therapeutics, Inc. and Pharvaris N.V. are both Biotechnology companies. Celldex Therapeutics, Inc. and Pharvaris N.V. are of similar size ($2.3B and $2.2B). Pharvaris N.V. has the higher net margin (0.00% vs −33,883.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Pharvaris N.V. leads on 9 and Celldex Therapeutics, Inc. on 4.

Valuation

Metric CLDX PHVS Biotechnology median
P/E n/m n/m 10.26
P/S 2,497.55 n/m 9.18
P/B 3.10 6.38 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 1,691.39 n/m 8.98
Earnings yield (15.28%) (9.30%) (34.89%)
Free cash flow yield (10.93%) (7.98%) (24.52%)

Profitability

Metric CLDX PHVS Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (36,733.82%) 0.00% 0.00%
Net margin (33,883.77%) 0.00% 0.00%
Free cash flow margin (27,294.81%) 0.00% 0.00%
Return on equity (43.88%) (71.50%) (50.12%)
Return on assets (40.76%) (64.43%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLDX PHVS Biotechnology median
Revenue growth (TTM) (88.27%) — 6.26%
EPS growth (last fiscal year) (59.18%) (25.37%) 29.88%
Revenue growth, 5-year CAGR (26.93%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLDX PHVS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.82 11.94 4.89
Net debt to EBITDA 1.78 1.72 1.01

Dividend

Metric CLDX PHVS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLDX PHVS Biotechnology median
Market cap 2.22b 2.28b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack